Search results for the GEO ID: GSE7095
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM170692
GPL201
LPS-activated DCs, Donor A (A1) Monocyte-derived dendritic cells LPS-activated DCs, Donor A Monocyte-derived DCs from donor A were activated with LPS for 12 h. An aliquot of cells were assayed by FACS to ensure the mature phenotype of the dendritic cells after LPS treatment.
GSM170693
GPL201
Viral IL-10 treated LPS-activated DCs, Donor A (A2) Monocyte-derived dendritic cells Viral IL-10 treated LPS-activated DCs, Donor A Monocyte-derived DCs from donor A were activated with LPS for 12 h. An aliquot of cells were assayed by FACS to ensure the mature phenotype of the dendritic cells after LPS and IL-10 treatment.
GSM170694
GPL201
Untreated immature DCs, Donor A (A4) Monocyte-derived dendritic cells Untreated immature DCs, Donor A Monocyte-derived DCs from donor A were left unstimulated. An aliquot of cells were assayed by FACS to ensure the immature phenotype of the dendritic cells.
GSM170695
GPL201
LPS-activated DCs, Donor B (B1) Monocyte-derived dendritic cells LPS-activated DCs, Donor B Monocyte-derived DCs from donor B were activated with LPS for 12 h. An aliquot of cells were assayed by FACS to ensure the mature phenotype of the dendritic cells after LPS treatment.
GSM170696
GPL201
Viral IL-10 treated LPS-activated DCs, Donor B (B2) Monocyte-derived dendritic cells Viral IL-10 treated LPS-activated DCs, Donor B Monocyte-derived DCs from donor B were activated with LPS for 12 h. An aliquot of cells were assayed by FACS to ensure the mature phenotype of the dendritic cells after LPS and IL-10 treatment.
GSM170697
GPL201
Untreated immature DCs, Donor B (B4) Monocyte-derived dendritic cells Untreated immature DCs, Donor B Monocyte-derived DCs from donor B were left unstimulated. An aliquot of cells were assayed by FACS to ensure the immature phenotype of the dendritic cells.
GSM170698
GPL201
LPS-activated DCs, Donor D (D1) Monocyte-derived dendritic cells LPS-activated DCs, Donor D Monocyte-derived DCs from donor D were activated with LPS for 12 h. An aliquot of cells were assayed by FACS to ensure the mature phenotype of the dendritic cells after LPS treatment.
GSM170699
GPL201
Viral IL-10 treated LPS-activated DCs, Donor D (D2) Monocyte-derived dendritic cells Viral IL-10 treated LPS-activated DCs, Donor D Monocyte-derived DCs from donor D were activated with LPS for 12 h. An aliquot of cells were assayed by FACS to ensure the mature phenotype of the dendritic cells after LPS and IL-10 treatment.
GSM170700
GPL201
Human IL-10 treated LPS-activated DCs, Donor D (D3) Monocyte-derived dendritic cells Human IL-10 treated LPS-activated DCs, Donor D Monocyte-derived DCs from donor D were activated with LPS for 12 h. An aliquot of cells were assayed by FACS to ensure the mature phenotype of the dendritic cells after LPS and IL-10 treatment.
GSM170701
GPL201
Untreated immature DCs, Donor D (D4) Monocyte-derived dendritic cells Untreated immature DCs, Donor D Monocyte-derived DCs from donor D were left unstimulated. An aliquot of cells were assayed by FACS to ensure the immature phenotype of the dendritic cells.
GSM170702
GPL201
LPS-activated DCs, Donor E (E1) Monocyte-derived dendritic cells LPS-activated DCs, Donor E Monocyte-derived DCs from donor E were activated with LPS for 12 h. An aliquot of cells were assayed by FACS to ensure the mature phenotype of the dendritic cells after LPS treatment.
GSM170703
GPL201
Viral IL-10 treated LPS-activated DCs, Donor E (E2) Monocyte-derived dendritic cells Viral IL-10 treated LPS-activated DCs, Donor E Monocyte-derived DCs from donor E were activated with LPS for 12 h. An aliquot of cells were assayed by FACS to ensure the mature phenotype of the dendritic cells after LPS and IL-10 treatment.
GSM170704
GPL201
Human IL-10 treated LPS-activated DCs, Donor E (E3) Monocyte-derived dendritic cells Human IL-10 treated LPS-activated DCs, Donor E Monocyte-derived DCs from donor E were activated with LPS for 12 h. An aliquot of cells were assayed by FACS to ensure the mature phenotype of the dendritic cells after LPS and IL-10 treatment.
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes